Back to results
US 2026/0028335 A1Published application
Novel isothiazol-3-yl and isoxazol-3-yl sulfonamide compounds
AssigneeHoffmann-La Roche Inc.
InventorsGuido GALLEY, Luca Claudio GOBBI, Wolfgang GUBA, Dmitry MAZUNIN, Emmanuel PINARD, Antonio RICCI
Life of this patent
Estimating the term…
Abstract
The invention relates to novel compounds having the general formula (I) wherein R1, R2, R3, X and Y are as described herein, composition including the compounds and methods of using the compounds.
Claims18
Compounds of formula I
- wherein,
- R1 is alkyl, alkoxy, cyano, cyanoalkyl, cyclopropyl, or halo;
- R2 is H, alkyl, alkoxy, cyano, cyclopropyl or halo;
- R3 is halo, alkyl, or haloalkyl;
- X is —O— or —S—;
- Y is CH or N;
- and pharmaceutically acceptable salts thereof.
4 more elements
13-14. (canceled)
16-20. (canceled)
23-24. (canceled)
Dependencies are inferred from the claim text.